Legal provisions of COM(2008)684 - Amendment of Council Regulation (EC) No 713/2005 imposing a definitive countervailing duty on imports of certain broad spectrum antibiotics from India

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2008)684 - Amendment of Council Regulation (EC) No 713/2005 imposing a definitive countervailing duty on imports of certain broad ...
document COM(2008)684 EN
date November 27, 2008

Contents

Article 1

Paragraph 2 of Article 1 of Regulation (EC) No 713/2005 shall be replaced by the following:

‘2.   The rate of duty applicable to the net free-at-Community-frontier price, before duty for imports produced in India by the companies listed below, shall be as follows:

—17,3 % for KDL Biotech Ltd, Mumbai (TARIC additional code: A580),

—28,1 % for Nectar Lifesciences Ltd, Chandigarh (TARIC additional code: A581),

—25,3 % for Nestor Pharmaceuticals Ltd, New Delhi (TARIC additional code: A582),

—11,9 % for Ranbaxy Laboratories Ltd, New Delhi (TARIC additional code: 8221),

—28,1 % for Torrent Gujarat Biotech Ltd, Ahmedabad (TARIC additional code: A583),

—28,1 % for Surya Pharmaceuticals Ltd, Chandigarh (TARIC additional code: A584),

—32 % for all other companies (TARIC additional code: 8900).’

Article 2

This Regulation shall enter into force on the day following its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.